newsfilter
← Latest News
GlobeNewswire·

OpGen Reports Second Quarter 2022 Financial Results and Provides Business Update

Total Q2 2022 revenues of $1.0 million with product sales a key growth driver First two commercial customer contracts for Acuitas AMR Gene Panel signed in June and July 2022 Requested additional 180-day period to regain compliance with Nasdaq minimum